Exelixis Aktie
35,18
EUR
-0,44
EUR
-1,24
%
36,20
USD
-0,34
USD
-0,93
%
Werbung
Exelixis Aktie Analyse
22.02.19 | Exelixis Market Perform | BMO Capital Markets | |
11.05.18 | Exelixis Buy | Needham & Company, LLC | |
17.10.17 | Exelixis Buy | Needham & Company, LLC | |
17.10.17 | Exelixis Outperform | RBC Capital Markets | |
15.09.17 | Exelixis Outperform | RBC Capital Markets | |
12.09.17 | Exelixis Buy | Needham & Company, LLC | |
31.03.17 | Exelixis Buy | Needham & Company, LLC | |
28.02.17 | Exelixis Hold | Stifel, Nicolaus & Co., Inc. | |
Werbung
|
|||
03.11.16 | Exelixis Buy | Deutsche Bank AG | |
15.09.16 | Exelixis Buy | Stifel, Nicolaus & Co., Inc. | |
26.04.16 | Exelixis Buy | Stifel, Nicolaus & Co., Inc. | |
04.04.16 | Exelixis Buy | Stifel, Nicolaus & Co., Inc. | |
30.11.12 | Exelixis buy | Stifel, Nicolaus & Co., Inc. | |
16.10.08 | Exelixis buy | Merriman Curhan Ford & Co | |
29.03.06 | Exelixis buy | WR Hambrecht+Co | |
14.03.06 | Exelixis outperform | Piper Jaffray | |
05.01.06 | Exelixis outperform | Piper Jaffray | |
08.12.05 | Exelixis buy | Banc of America Sec. | |
31.08.05 | Exelixis | Der Aktionär | |
11.07.05 | Exelixis buy | Banc of America Sec. | |
08.07.05 | Exelixis Buy | Banc of America Sec. | |
01.07.05 | Exelixis buy | Fortis | |
30.06.05 | Exelixis Buy | Fortis | |
30.06.05 | Exelixis | Der Aktionär | |
14.06.05 | Exelixis | Biotech-Report | |
12.01.05 | Exelixis Buy | Sun Trust Robinson Humphrey |
Werbung